Skip to main content

Table 1 Demographic and clinical manifestations in pediatric IgA vasculitis according to different onset ages

From: Onset age is a risk factor for refractory pediatric IgA vasculitis: a retrospective cohort study

 

Total (n = 484)

≤6 Y (n = 234)

6–12 Y (n = 210)

12–18 Ya (n = 40)

P value

Onset age, years old

6.10 (4.72–8.58)

4.68 (3.83–5.27)

7.91 (6.88–9.55)

14.48 (12.97–15.90)

 

Male sex

252 (52.1%)

122 (52.1%)

110 (52.4%)

20 (50.0%)

0.962

Preceding infection

304 (62.8%)

168 (71.8%)

118 (56.2%)

16 (40.0%)

< 0.001

Manifestation

 Skin purpura

484 (100%)

234 (100%)

210 (100%)

40 (100%)

NA

 Arthralgia/arthritis

361 (74.6%)

192 (82.1%)

151 (71.9%)

18 (45.0%)

< 0.001

 CNS/PNS involvement

5 (1.0%)

2 (0.9%)

2 (1.0%)

1 (2.5%)

NA

 GI involvement

311 (64.3%)

156 (66.7%)

130 (61.9%)

25 (62.5%)

0.562

 Abdominal pain

294 (60.7%)

147 (62.8%)

123 (58.6%)

24 (60.0%)

0.654

 Vomiting

100 (20.7%)

50 (21.4%)

44 (21.0%)

6 (15.0%)

0.649

 Diarrhea

34 (7.0%)

11 (4.7%)

18 (8.6%)

5 (12.5%)

0.103

 GI bleeding

42 (8.7%)

23 (9.8%)

15 (7.1%)

4 (10.0%)

0.576

 Positive stool occult blood

111 (22.9%)

56 (23.9%)

44 (21.0%)

11 (27.5%)

0.586

 Renal involvement

130 (26.9%)

43 (18.4%)

65 (31.0%)

22 (55.0%)

< 0.001

 Microscopic hematuria

129 (26.7%)

43 (18.5%)

64 (30.5%)

22 (55.0%)

< 0.001

 Gross hematuria

10 (20.7%)

4 (1.7%)

6 (2.9%)

0

NA

 Non-nephrotic proteinuria

24 (5.0%)

8 (3.4%)

13 (6.2%)

3 (7.5%)

0.301

 Nephrotic syndrome

8 (1.7%)

2 (0.9%)

5 (2.4%)

1 (2.5%)

NA

  1. Data shown are median (IQR) or number (%) of patients as appropriate
  2. Abbreviations: IgA Immunoglobulin A, CNS Central nervous system, PNS Peripheral nervous system, GI Gastrointestinal, NA Not available
  3. a Patients were grouped by onset age: ≤ 6 Y (years old), 6–12 Y (> 6, ≤ 12 years old), and 12–18 Y (> 12, < 18 years old)